Sees FY23 adjusted EBITDA $17M-$20M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TRHC:
- Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
- Medication Management Services Leader Cureatr Acquires SinfoníaRx
- Tabula Rasa HealthCare Announces Preliminary Estimated Fourth Quarter 2022 Revenues From Continuing Operations
- Tabula Rasa HealthCare raises Q4 cont-op revenue view to $82M-$83M
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue